Oral Appliance in Obstructive Sleep Apnea. A Randomized Controlled Blinded Multicenter Study Comparing Two Devices
- Conditions
- Obstructive Sleep Apnea
- Registration Number
- NCT02148510
- Lead Sponsor
- Uppsala University
- Brief Summary
- The hypothesis of the study is that a bibloc-apnea splint has a comparable efficacy on respiratory measures as a monobloc-apnea splint and that the cost of treatment is the same. The goal is primarily to compare the Apnea-Hypopnea Index (AHI) after 6 weeks of treatment and the cost of treatment during one year. 
 This randomized controlled parallel group multicenter study includes 316 subjects referred for the treatment of moderate to severe Obstructive Sleep Apnea (OSA). The subjects visit the clinic at 5 scheduled occasions.
- Detailed Description
- The study includes 2 arms. Secondary measures are obtained by respiratory analysis and questionnaires. Electromyography (EMG) of the masseter muscle is recorded and the influence of bruxism is evaluated in terms effect on efficacy and adverse events 
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 313
- The diagnosis of obstructive sleep apnea with AHI > 15
- Odontological status that allows retention of oral devices and with at least one molar in each quadrant
- Maximal protrusion >6 mm
- Subject giving his/her informed concent
- Understands and can communicate in Swedish
- Subject understands the instruction on how to put on the polygraphy equipment at home
- Valid AHI data at baseline respiratory analysis
- age< 18 år
- BMI >35
- Jaw complaints requiring treatment the past year
- Pain or locking of the jaw at the enrollment visit
- At the discretion of the investigator judged not being able to attach to the study directives
- Hypersensitive to the material of the devices
- Ongoing Continuous Positive Airway Pressure (CPAP) treatment or oral device treatment or such treatment terminated within a month from enrollment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
- Name - Time - Method - Apnoea-Hypopnea-Index (AHI) - 9 weeks after start of study - AHI defined by American Academy of Sleep Medicine (AASM) 
- Secondary Outcome Measures
- Name - Time - Method - Adverse events - 1 year - Subject reported and objective investigator observed events - Sleepiness - 9 weeks and 1 year - Epworth Sleepiness Scale (ESS) - Oxygen Desaturation Index (ODI) - 9 weeks - Number of episodes per hour with arterial oxygen saturation decline of 3% or more - Quality of life - 9 weeks and 1 year - Functional Outcomes of Sleep Questionnaire (FOSQ ) - Sleep bruxism - 9 weeks - Bruxism episodes during sleep 
Trial Locations
- Locations (2)
- Västmanland County Hospitals 🇸🇪- Västerås, Västmanland, Sweden - Postgraduate Dental Education Center 🇸🇪- Örebro, Sweden Västmanland County Hospitals🇸🇪Västerås, Västmanland, Sweden
